Sunrise-2: A Phase 3, Multicenter, Randomized Study Evaluating The Efficacy Of Tar-200 In Combination With Cetrelimab Versus Concurrent Chemoradiotherapy In Participants With Muscle-Invasive Urothelial Carcinoma Of The Bladder
JOURNAL OF UROLOGY（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要